Siham  Sabri

Assistant Professor


MUHC Research Institute
1001 Decarie Boulevard
Montreal, Quebec H4A 3J1

Telephone: 514-934-1934, x44686

Education: Ph.D., M.Sc., Paris-7 Denis Diderot University, France; B.Sc., Mediterranean University (Aix-Marseille II, France)

Clinical Focus: Glioblastoma

Research Focus: Cancer Invasion, Angiogenesis, Biomarkers, Therapeutics Targets, Radiation-Induced Toxicities

Recent Presentations:

Mariia Patyka*, Bassam Abdulkarim, Yaoxian Xu, Siham Sabri. Differential response to radiation therapy based on MGMT and p53 status in glioblastoma multiforme. Poster presentation at the Targeted Anticancer Therapies (TAT) Congress. March 5-7, 2014. Washington, DC.

Siham Sabri, Maria Patyka* and Yaoxian Xu. Identification of new MGMT-binding partners in Glioblastoma using mass spectrometry-based proteomic approach. AACR Annual Meeting 2014, April 7, 2014. San Diego, CA, Poster Session Experimental and Molecular Therapeutics.

Ayman J. Oweida, Zeinab Sharifi, Yaoxian Xu, Siham Sabri, Bassam Abdulkarim. Evolving biological and clinical concepts of radiation delivery in NSCLC: response to ablative versus fractionated radiotherapy. AACR Annual Meeting 2014, April 6, 2014. San Diego, CA

Melissa Azoulay, Jose Mansure, George Shenouda, Maria Patyka*, Siham Sabri, Bassam Abdulkarim. Comparison of hypofractionated radiation with temozolomide to the current standard of care in the treatment of glioblastoma: Results from a single institution. ASCO Annual Meeting 2014, May 30 – June 3, 2014. Chicago, Illinois.

Siham Sabri, Mariia Patyka*, Yaoxian Xu. Relationship between the O6-Methylguanine-DNA Methyltransferase (MGMT) and mutated TP53 in glioblastoma and its significance in response to the p53 rescue compound APR-246/PRIMA-1MET. 19th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO). November 13 – 16, 2014. Miami, USA. Oral Presentation: E-Poster Discussion

Recent Publications:

Please click here for Dr. Siham Sabri's complete publication list.